medigraphic.com
SPANISH

Revista Mexicana de Anestesiología

ISSN 3061-8142 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
    • Políticas éticas
    • Políticas editoriales generales
    • Políticas de revisión de manuscritos
    • Políticas de acceso abierto
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number S1

<< Back Next >>

Rev Mex Anest 2026; 49 (S1)

Anesthetic management of the patient with aortic stenosis for valve replacement with reduced ventricular function

Higuera-Medina LE, Moya MA
Full text How to cite this article

Language: Spanish
References: 14
Page: 26-27
PDF size: 744.14 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guidelinefor the management of patients with valvular heart disease. J Am CollCardiol. 2021;77:e25-e197.

  2. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines forthe management of valvular heart disease. Eur Heart J. 2022;43:561-632.

  3. Thompson A, Fleischmann KE, Smilowitz NR, et al. 2024 AHA/ACCguideline for perioperative cardiovascular management for noncardiacsurgery. J Am Coll Cardiol. 2024;84:1869-1969.

  4. Landoni G, Lomivorotov VV, Nigro Neto C, et al. Volatile anestheticsversus total intravenous anesthesia for cardiac surgery. N Engl J Med.2019;380:1214-1225.

  5. Wahba A, Kunst G, De Somer F, et al. 2024 EACTS/EACTAIC/EBCPguidelines on cardiopulmonary bypass in adult cardiac surgery. Eur JCardiothorac Surg. 2025;67:ezae354.

  6. Mathew R, Di Santo P, Jung RG, et al. Milrinone as compared withdobutamine in the treatment of cardiogenic shock. N Engl J Med.2021;385:516-525.

  7. Mehta RH, Leimberger JD, van Diepen S, et al. Levosimendan in patientswith left ventricular dysfunction undergoing cardiac surgery. N Engl JMed. 2017;376:2032-2042.

  8. Thiele H, Kurz T, Feistritzer HJ, et al. General versus local anesthesiawith conscious sedation in TAVI: the randomized SOLVE-TAVI trial.Circulation. 2020;142:1437-1447.

  9. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aorticvalvereplacement in low-risk patients at five years. N Engl J Med.2023;389:1949-1960.

  10. Forrest JK, Yakubov SJ, Deeb GM, et al. 5-year outcomes after transcatheteror surgical aortic valve replacement in low-risk patients with aortic stenosis.J Am Coll Cardiol. 2025;85:1523-1532. doi: 10.1016/j.jacc.2025.03.004.

  11. Mehaffey JH, Johnston LE, Hawkins RB, et al. Methylene blue forvasoplegic syndrome after cardiac operation: early administrationimproves survival. Ann Thorac Surg. 2017;104:36-41.

  12. Lamelas P, Ragusa MA, Bagur R, et al. Clinical practice guideline fortranscatheter versus surgical valve replacement in patients with severeaortic stenosis in Latin America. Heart. 2021;107:1450-1457.

  13. Eid-Lidt G, Gaspar J, Arias A, et al. Primer caso de TAVI con EdwardsSapien XT en México. Arch Cardiol Mex. 2014;84:133-135.

  14. Lazcano-Díaz EA, Escamilla-Ríos DE, Torres Maldonado AS, et al.Endarterectomía carotídea en paciente con estenosis aórtica crítica.Importancia de la anestesia regional y del neuromonitoreo. Rev MexAnestesiol. 2023;46:140-143.




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Anest. 2026;49